Interoperability in the spotlight at fall AAMI-FDA summit

Seeking to identify the key safety issues involved in medical-device interoperability, the Association for the Advancement of Medical Instrumentation (AAMI) and the FDA are organizing a summit on the subject.

The gathering, slated for Oct. 2 and 3 in Herndon, Va., also will provide a forum to discuss prioritizing interoperability activities and consider the general challenges faced by healthcare providers working to connect medical devices and networks.

Interoperability is difficult to achieve in healthcare because of the need to maintain patient safety as a priority at all times, AAMI President Mary Logan, JD, said in a statement.

“Consider just the challenges in making wireless technologies work for medical devices that monitor life-threatening conditions, deliver medication infusions, direct alarms to caregivers or sustain life,” she said, adding that the complexity of the interoperability challenge in healthcare is “mind boggling.”

AAMI said the format will resemble that of previous AAMI summits. Recent such events have facilitated discussions on alarms management, reprocessing reusable medical devices and infusion pumps.
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.